UMIN-CTR Clinical Trial

Recruitment status Enrolling by invitation
Unique ID issued by UMIN UMIN000047154
Receipt No. R000053765
Scientific Title The efficacy of Subcutaneous Incision of the Fistula Tract and Internal Sphincterotomy(SIFT-IS) for transsphincteric anal fistulas
Date of disclosure of the study information 2022/03/15
Last modified on 2022/03/10 (Ver. 1)

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information
Public title The efficacy of Subcutaneous Incision of the Fistula Tract and Internal Sphincterotomy(SIFT-IS) for transsphincteric anal fistulas
Acronym The efficacy of SIFT-IS for anal fistulas
Scientific Title The efficacy of Subcutaneous Incision of the Fistula Tract and Internal Sphincterotomy(SIFT-IS) for transsphincteric anal fistulas
Scientific Title:Acronym The efficacy of SIFT-IS for anal fistulas
Region
Japan

Condition
Condition Transsphincteric anal fistula
Classification by specialty
Surgery in general
Classification by malignancy Others
Genomic information NO

Objectives
Narrative objectives1 To assess the efficacy of SIFT-IS in patients with transsphincteric anal fistulas
Basic objectives2 Safety
Basic objectives -Others
Trial characteristics_1
Trial characteristics_2
Developmental phase

Assessment
Primary outcomes Postoperative healing rate at 16 weeks
Key secondary outcomes Healing time,postoperative complications,and clinical continence status

Base
Study type Interventional

Study design
Basic design Single arm
Randomization Non-randomized
Randomization unit
Blinding Open -no one is blinded
Control Uncontrolled
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment

Intervention
No. of arms 1
Purpose of intervention Treatment
Type of intervention
Maneuver
Interventions/Control_1 Performing SIFT-IS for transsphincteric anal fistula
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10

Eligibility
Age-lower limit

Not applicable
Age-upper limit

Not applicable
Gender Male and Female
Key inclusion criteria Transsphincteric anal fistula
Key exclusion criteria Complicated fistulas(multiple fistulas,recurrent fistula,and horseshoe fistula)
IBD associated fistulas
Target sample size 100

Research contact person
Name of lead principal investigator
1st name Rikisaburo
Middle name
Last name Sahara
Organization Makita General Hospital
Division name Division of Coloproctology
Zip code 143-8505
Address 4-22-1 Nishikamata,Ohta-ku,Tokyo 143-8505,Japan
TEL 03(5748)5020
Email riki58sahara@gmail.com

Public contact
Name of contact person
1st name Koji
Middle name
Last name Morimoto
Organization Nishiarai Coloproctology Clinic
Division name Division of Coloproctology
Zip code 121-0815
Address 3-7-13 Shimane,Adachi-ku,Tokyo 121-0815 Japan
TEL 03(3883)2020
Homepage URL
Email morimo69@gmail.com

Sponsor
Institute JCHO Tokyo Yamate Mrdical Center
Institute
Department

Funding Source
Organization Nishiarai Coloproctology Clinic
Organization
Division
Category of Funding Organization Other
Nationality of Funding Organization

Other related organizations
Co-sponsor
Name of secondary funder(s)

IRB Contact (For public release)
Organization JCHO Tokyo Yamate Medical Center
Address 3-22-1 Hyakunin-cho,Shinjuku-ku,Tokyo 169-0073,Japan
Tel 03(3364)0251
Email morimo69@gmail.com

Secondary IDs
Secondary IDs NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW

Institutions
Institutions

Other administrative information
Date of disclosure of the study information
2022 Year 03 Month 15 Day

Related information
URL releasing protocol
Publication of results Unpublished

Result
URL related to results and publications
Number of participants that the trial has enrolled
Results
Results date posted
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description

Progress
Recruitment status Enrolling by invitation
Date of protocol fixation
2016 Year 01 Month 01 Day
Date of IRB
2021 Year 09 Month 30 Day
Anticipated trial start date
2016 Year 01 Month 01 Day
Last follow-up date
2025 Year 12 Month 31 Day
Date of closure to data entry
Date trial data considered complete
Date analysis concluded

Other
Other related information

Management information
Registered date
2022 Year 03 Month 11 Day
Last modified on
2022 Year 03 Month 10 Day


Link to view the page
URL(English) https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000053765